Nephron Initiates Humana(HUM.US) With Hold Rating, Announces Target Price $294

Futu News55minutes ago · Ratings

Nephron Research Downgrades Humana to Hold From Buy, $294 Price Target

MT NewswiresDec 11 20:49 · Ratings

Luigi Mangione Charged With Murder of UnitedHealthcare CEO. He Was Carrying a Ghost Gun.

BarronsDec 10 18:56

Police Find 'Person of Interest' in UnitedHealth Group Killing

BarronsDec 10 01:57

UnitedHealth Group Stock Is Rising. Manhunt for Executive's Killer Continues. -- Barrons.com

Barron'sDec 9 21:07

The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA

Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.

wallstreetcnDec 9 11:20